List of Clario eCOA Clinical Trials Customers
Philadelphia, 19103, PA,
United States
Since 2010, our global team of researchers has been studying Clario eCOA Clinical Trials customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Clario eCOA Clinical Trials for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Clario eCOA Clinical Trials for Clinical Trial Management include: GSK, a United Kingdom based Life Sciences organisation with 69310 employees and revenues of $42.21 billion, Johnson & Johnson Innovative Medicine, a United States based Life Sciences organisation with 40000 employees and revenues of $20.00 billion and many others.
Contact us if you need a completed and verified list of companies using Clario eCOA Clinical Trials, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Clario eCOA Clinical Trials customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | Clario | Clario eCOA Clinical Trials | Clinical Trial Management | 2024 | n/a |
In 2024, GSK deployed Clario eCOA Clinical Trials to support Clinical Trial Management activities focused on study delivery and country management across global development programs. The implementation was positioned to support Study Delivery Specialist responsibilities including vendor oversight, regulatory submission coordination, and site activation workflows within study teams.
Clario eCOA Clinical Trials was configured to handle electronic patient reported outcome capture and to align with study documentation standards. Configuration and operational modules included CSAP setup and maintenance, eTMF completeness checks, access management for vendors and sites, and the creation and review of study documents such as protocol text, study delivery plans, TMF quality strategy documents, pharmacy manuals, and investigator site newsletters. The implementation also included establishing STOM governance within studies.
Operationally the program centralized vendor management across Clario eCOA and third party providers named in program oversight, specifically Q2 lab, JUMO Health, Human8, and MMG, with formal processes for document review and development, communication plans, specifications, oversight plans, task and change order management, invoice review and approval, and escalation to the Study Delivery Lead when needed. The deployment was integrated into CTMS activities and supported TCS oversight, regulatory submission tracking at the country level, site activation coordination, and first line vendor issue resolution.
Governance and workflow changes were codified through vendor management plans, communication plans, oversight plans, and routine PD review meetings to drive consistency between systems and contractual agreements. The Study Delivery Specialist role managed access controls, RIM risk entries, vIM activities, and ongoing CSAP maintenance to sustain operational discipline for Clinical Trial Management.
|
 |
Johnson & Johnson Innovative Medicine | Life Sciences | 40000 | $20.0B | United States | Clario | Clario eCOA Clinical Trials | Clinical Trial Management | 2022 | n/a |
In 2022, Johnson & Johnson Innovative Medicine implemented Clario eCOA Clinical Trials for Clinical Trial Management to support program-level operations across Phase II/III and Phase III studies in infectious disease, pediatrics, and immunology. The deployment targeted the Clinical Operations function, with the Study Management Team led by a program/coordinating Clinical Trial Manager overseeing a team of five CTMs, Local Trial Managers, and Clinical Research Associates.
The Clario eCOA Clinical Trials implementation centered on electronic clinical outcome assessment workflows, patient reported outcome capture, site and subject scheduling, and monitoring capabilities consistent with Clinical Trial Management platforms. Study-level configuration aligned eCOA instruments and visit schedules with the teams responsible for feasibility and site selection, and the CTM role included configuration oversight to ensure study deliverables and timelines were met.
Operational integration was coordinated with other vendor systems managed by the clinical operations group, including Labcorp for laboratory data, DrugDev for trial communications, and IWRS for randomization and supply management, enabling handoffs across data collection, lab feeds, and enrollment workflows. Governance rested in the Study Management Team structure, with CTMs directing site onboarding and vendor oversight, CRAs and LTMs adopting eCOA workflows for source data capture, and study processes updated to incorporate eCOA scheduling and monitoring into routine clinical operations.
|
Buyer Intent: Companies Evaluating Clario eCOA Clinical Trials
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||